FDA Warning Wire: Wockhardt Again In FDA Crosshairs

The U.S. Food and Drug Administration once again scolded drugmaker Wockhardt for testing and record-keeping issues at a subsidary's plant, an issue that's caused trouble for the drugmaker in the past,...

Already a subscriber? Click here to view full article